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Purpose: The aim of the present study was to investigate associations between the 
renin gene (REN) and the risk of essential hypertension and blood pressure (BP) lev-
els in Koreans. Materials and Methods: To outline the functional role of a single 
nucleotide polymorphism in the transcription of the REN gene, we conducted a case-
control study of 1975 individuals: 646 hypertension (HT) patients and 1329 ethnical-
ly and age-matched normotensive subjects. Results: Logistic regression analysis in-
dicated that the genotypes AA/AG were strongly associated with risk of HT (odds 
ratio, 1.493; 95% confidence interval, 1.069‒2.086, p=0.018) in female subjects. The 
genotypes AA/AG also showed significant association with higher blood pressure 
levels, both systolic and diastolic, in postmenopausal HT women (p=0.003 and 
p=0.017, respectively). Analysis of the promoter containing rs6682082 revealed a 
2.4±0.01-fold higher activity in the A variant promoter than the G variant promot-
er, suggesting that rs6682082 is itself a functional variant. Conclusion: We sug-
gest that the A allele of rs6682082 is a positive genetic marker for predisposition 
to essential hypertension and high BP in Korean women and may be mediated 
through the transcriptional activation of REN.
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INTRODUCTION
Hypertension is a major risk factor for cardiovascular diseases, such as stroke, 
myocardial infarction, heart failure, and vascular disease. The early screening and 
identification of patients at risk is essential for preventing target organ damage and 
reducing mortality. Hypertension is considered a multi-factorial disease since its 
development is affected by both genetic and environmental factors.1,2
Intense efforts have been focused on identifying gene(s) related to hypertension. 
Recently, large-scale genome-wide association studies have uncovered an associa-
tion between hypertension and/or blood pressure and several genes not previously 
identified.3-5 Among the single-nucleotide polymorphisms (SNPs) shown to be as-
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scription of REN.19 Recently, a few SNPs in the 5’ upstream 
region of the REN gene have been shown to be positively 
associated with EH. However, the relationship between the 
renin expression and these polymorphisms is unclear.19 
In the present study, we sought to determine the genetic 
contribution of renin to essential hypertension in Koreans 
and identified a positive association between the rs6682082 
polymorphism in the promoter of the REN gene and EH, as 
well as increased blood pressure levels, in Korean women. 
We also demonstrated the functional role of this SNP in the 
transcription of the REN gene using a heterologous expres-
sion system. Based on these data, we discussed the relation-
ship between the genetic variant and its molecular biologi-
cal function in regards to EH in Korean women.
MATERIALS AND METHODS
Study subjects
The 1975 individuals, 646 EH patients and 1329 normoten-
sive subjects, who participated in this study were recruited 
by the Cardiovascular Genome Center of Yonsei University 
and the National Genome Research Institute of Korea. Hy-
pertension patients were defined as those with a systolic 
blood pressure ≥140 mm Hg or a diastolic blood pressure 
≥90 mm Hg or those who were being administered antihy-
pertensive agents. Patients with secondary hypertension, re-
nal failure, diabetes mellitus, or significant hepatic disease 
or who were on corticosteroid therapy were excluded. Nor-
motensives were defined as those with a blood pressure 
<140/90 mm Hg without a history of hypertension, renal in-
sufficiency, significant hepatic disease, diabetes, or apparent 
coronary artery disease. The Ethics Committees of Yonsei 
University, as well as The Catholic University of Korea, ap-
proved this project, and all participants gave written, in-
formed consent. All demographic data were collected via 
medical records and direct measurement by blood chemistry. 
Genetic analysis 
Genomic DNA was extracted from peripheral blood using 
a commercial genomic DNA purification kit (Promega, 
Madison, WI, USA). Genotypes rs6682082, rs11240688, 
rs10900555, rs2272237, rs1464816, and rs2368564 were 
determined by a single-base primer extension assay using 
the ABI PRISM SNaPshot kit (Applied Biosystems, Foster 
City, CA, USA) according to the manufacturer’s recom-
mendation. Primer sequences for rs6682082 were as fol-
sociated with blood pressure or hypertension, ATP2B1 and 
CYP17A1, as well as a few others, were found to be associ-
ated with the phenotype in different ethnic groups, while 
some of them were not.6 Surprisingly, genome-wide associa-
tion studies have not found associations between renin-an-
giotensin system (RAS) genes and hypertension or blood 
pressure, despite extensive study.7
Candidate-gene-based association studies are still popu-
lar for identifying genetic components of essential hyper-
tension (EH), and the genes of the RAS have been exten-
sively studied as candidate genes associated with EH. Renin, 
a protease expressed mainly in the juxtaglomerular cells of 
the kidney, cleaves angiotensinogen to angiotensin I, which 
is in turn further processed to angiotensin II by angiotensin 
converting enzyme I. Angiotensin II is a potent vasocon-
strictor and stimulates the release of aldosterone and vaso-
pressin, thus contributing to an increase in blood pressure. 
Renin catalyzes the first and rate-limiting step of the RAS 
cascade, thereby playing a crucial role in the regulation of 
blood pressure and electrolyte homeostasis.8 Human renin 
gene (REN) is composed of 12 exons dispersed across 12 
kb of human chromosome 1q32. Several polymorphic 
markers within the renin gene have been investigated for 
their associations with EH and blood pressure in various 
ethnic groups, showing contradictory results. Whereas 
many studies have shown negative associations between re-
nin polymorphisms and EH,5,9-11 positive associations have 
also been reported in several ethnic groups, including two 
independent United Emirates populations, a Caucasian 
group in the USA, and two large Spanish populations, as 
well as Han, Tibetan, Mongolian, Indian, and a few other 
population groups.12-18
The expression of the renin gene is tightly regulated at the 
transcriptional level and its regulation is genetically con-
trolled. Transcription of the human REN gene is dependent 
on three regions: a proximal promoter region, a tissue-spe-
cific element region, and an enhancer region.19 In the proxi-
mal promoter region of the human REN gene, various cis-
acting elements have been identified, including a cAMP 
response element, a Pit-1 consensus binding site, an Ets-mo-
tif-like site, a HOX-PBX recognition sequence, COUP-
TFII-motif-like sites, and a hormone responsive element.20-22 
Mutations in some of these elements modulate the expres-
sion of renin.23
Several SNPs have been identified in the promoter and en-
hancer regions of the human REN gene.24,25 Among those, 
only one (rs12750834) has been shown to affect the tran-
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by the manufacturer, with the following primers, 5’-TTA 
GGC CAG CTA CCA AAA ACG CAA AGA AAA ACT 
TTC TGT AG-3’ and 5’-CTA CAG AAA GTT TTT CTT 
TGC GTT TTT GGT AGC TGG CCT AA-3’. PCR reac-
tion was carried out in a 20 µL reaction mixture containing 
10 ng of the original G type plasmid. The positive clone 
was verified by DNA sequence analysis.
The promoter activity was determined by the luciferase ac-
tivity of the cells transfected with each plasmid. As 4.1 cells 
were grown in DMEM supplemented with 10% FBS, 100 
μg/mL penicillin, and 100 μg/mL streptomycin at 37°C in a 
humidified 5% CO2 incubator. Five hundred nanograms of 
the plasmid DNA was transiently co-transfected with 100 ng 
of beta-galactosidase-expression vector into 1×105 cells in a 
six-well culture plate using polyethylenimine.26 Twenty-four 
hours later, the medium was used to measure luciferase activ-
ity using BioLuxTM Gaussian Luciferase Assay kit (NEB, 
Beverly, MA, USA), following the manufacturer’s manual, 
and a Luminometer (Turner Designs, Promega, Madison, 
WI, USA). Luciferase activity was normalized against trans-
fection efficiency determined by β-galactosidase activity. The 
promoter activity was obtained by subtracting the back-
ground activity of the pGLuc basic vector. Two independent 
experiments were performed in duplicate. The promoter ac-
tivity was presented as the mean±standard error. The fold dif-
ference was calculated against the G type promoter activity. 
Data were compared by two-tailed Student’s t-test.
 
RESULTS
 
Clinical characteristics of the study participants 
A total of 1975 individuals, 646 EH patients and 1329 nor-
motensive subjects, participated in this study, and their char-
acteristics are presented in Table 1. The hypertensive group 
exhibited significantly higher systolic and diastolic blood 
pressures. There were significant differences between the 
HT and NT groups in their BMI and levels of creatinine, 
triglycerides (TG), HDL, and glucose (Glu), whereas age 
and total cholesterol and low-density lipoprotein levels did 
not differ between the two groups in either the male or fe-
male participants. 
Association between the renin polymorphism rs6682082 
and EH or blood pressure
We prescreened 184 subjects (92 cases and 92 controls) for 
association with EH in our study population. They were gen-
lows: forward 5’-TGT TTC CCA GCC TAA AAT AAT-3’, 
reverse 5’-ACA GGT TAT CTA AAT GGG CTT C-3’; 
probe: 5’-TCA CAC TAC AGA AAG TTT TTC TTT G-3’. 
The genotyping of rs6682082 was carried out using an ABI 
prism 3730XL DNA analyzer.
Statistical analysis
The statistical analyses were carried out using the SAS pro-
gram (version 9.2, SAS Institute Inc., Cary, NC, USA). Link-
age dysequilibrium (LD) was calculated using Haploview 
4.2. Analyses of clinical characteristics were carried out us-
ing a normality test and Student’s t-test. Student’s t-test and 
χ2 analyses were used to compare the mean values between 
groups for continuous or categorical measurements, respec-
tively. The Hardy-Weinberg equilibrium (HWE) was as-
sessed by χ2 analysis. Frequencies of genotype and alleles 
were compared using χ2 tests or Fisher’s exact test. The rela-
tionship between genotypes and the risk of EH was reported 
in odds ratios (ORs), which were calculated with 95% confi-
dence intervals (CIs). The OR was adjusted for body mass 
index (BMI), creatinine, triglyceride (TG), high-density lipo-
protein (HDL), and glucose (Glu). A value of p<0.05 was 
considered statistically significant. The relationship between 
the genotypes of rs6682082 and blood pressure was ana-
lyzed using Student’s t-test and Wilcoxon signed rank test. 
Blood pressure was presented as the mean± standard error.
Construction of plasmids and analysis of the promoter 
activities
A 2869 bp product of the proximal region of the human re-
nin gene promoter was amplified from genomic DNA by 
PCR using the primers Renin F (5’-CTT GGT AGG ATC 
CCT GTG GCT A-3’) and Renin R (5’-CTC AGT CTG 
GGG CTC TCT CTG-3’). The PCR product was cloned 
into pGEM-Teasy (Promega, Madison, WI, USA), and an 
EcoRI restriction fragment of this construct was inserted 
into the EcoRI-digested pGLuc basic vector (New England 
Biolabs, Beverly, MA, USA). This yielded a construct with 
the firefly luciferase reporter gene under control of the hu-
man renin gene promoter. Genomic DNAs from female ho-
mozygotes for the A allele or G allele were used for amplifi-
cation of the Ren promoter region. To generate a G (A) 
promoter plasmid that contained the G type sequence across 
the whole promoter region, with the exception of A at the 
rs6682082 polymorphic site, we performed site-directed 
mutagenesis using the QuikChange site-Directed Mutagen-
esis kit (Stratagene, La Jolla, CA, USA), as recommended 
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rs6682082 and EH, we used Fisher’s exact test and χ2 analy-
sis; the results are shown in Table 2. The overall genotype 
distribution and allele frequencies of rs6682082 differed sig-
nificantly between the HT and NT groups. Specifically, the 
frequency of the A allele was much higher in the HT group 
than the NT group (0.135 vs. 0.111, respectively; p=0.028) 
when the whole study group was analyzed. This significant 
difference remained in the female group only when the study 
population was subdivided based on sex (Table 2). The fre-
quency of the A allele was higher in the HT group than in the 
NT group (0.126 vs. 0.096, respectively; p=0.038), and the 
frequency of the AG/AA genotype was also higher in the hy-
pertensive group (0.250 vs. 0.185, respectively; p=0.015). 
A logistic regression analysis revealed that the OR for hy-
pertension in subjects with the AG or AA genotype was 
1.454 (95% CI=1.047‒2.018) in the female participants. This 
otyped for rs6682082, rs11240688, rs10900555, rs2272237, 
rs1464816, and rs2368564, which were selected based on 
their relative position on the renin gene, as well as their fre-
quencies as described in the dbSNP database (http://www.
ncbi.nlm.nih.gov/SNP/GeneGt.cgi?rpttype=Ldplot&geneID
=5972&chr=1&popID=1411) for Asian populations (Sup-
plementary Table 1, only online). Six SNPs were not in LD 
in Koreans (Supplementary Fig. 1, only online). Among the 
six SNPs investigated, we further investigated rs6682082 
only, using the expanded study population, because only 
rs6682082 displayed a marginal tendency for the association 
with EH (p=0.149). We genotyped all 1975 subjects for the 
rs6682082 SNP. The observed and expected genotypes 
agreed well with the predicted HWE in all groups, with the 
exception of the female hypertensive group (p=0.025). 
To determine whether an association existed between 
Table 1. Clinical Characteristics of the Participants in the Study Population 
Variables
Male Female
NT HT p value NT HT p value
Number 676 294 653 352
Age (yrs) 52.07±9.77 51.66±9.89 0.542 51.26±9.91 51.88±8.44 0.302
onSBP* (mm Hg) 108.08±12.48 161.68±21.20 0.000 111.51±12.17 159.49±23.62 0.000
onDBP* (mm Hg) 69.97±8.94 103.64±13.96 0.000 71.06±7.65 100.27±16.73 0.000
BMI (kg/m2) 22.63±2.48 25.35±2.88 0.000 22.86±2.77 24.74±3.28 0.000
Creatinine (mg/dL)   0.92±0.16   0.87±0.17 0.000   0.67±0.15   0.64±0.17 0.005
TG (mg/dL) 133.24±79.55 162.00±78.73 0.000 117.25±64.30 140.45±69.46 0.000
TCHOL (mg/dL) 193.61±35.68 197.78±36.74 0.097 201.22±36.78 203.35±41.19 0.402
HDL-C (mg/dL)   48.26±11.88   42.91±10.73 0.000   52.08±12.17   48.43±11.96 0.000
LDL-C (mg/dL) 118.69±33.81 122.46±33.53 0.110 125.70±34.43 126.82±35.86 0.626
Glu (mg/dL)   88.66±16.37   85.57±14.42 0.006   85.57±14.42   85.50±16.38 0.000
Meno-pause status known (n) 
    Pre- - - - 216 116 -
    Post- - - - 214 234 -
NT, normotensives; HT, hypertensives; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; TG, triglyceride; TCHOL, total 
cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Glu, glucose.
Data values are means±standard deviation and numbers. Age difference was not significant. p-value was estimated by Student’s t-test.
*SBP and DBP were BP prior to medication. 
Table 2. Renin rs6682082 Genotype/Allele Distribution in the Study Population 
Genotype/Allele
Male Female
NT (n=676) HT (n=294) p value NT (n=653) HT (n=352) p value
AA        9 (0.013)     9 (0.031)
0.175
      5 (0.008)     1 (0.003)
  0.018*AG   150 (0.222)   67 (0.228)   116 (0.178)   87 (0.247)
GG   517 (0.765) 218 (0.741)   532 (0.815) 264 (0.750)
AA, AG   159 (0.235)   76 (0.259) 0.436   121 (0.185)   88 (0.250) 0.015
A   168 (0.124)   85 (0.145)
0.222
  126 (0.096)   89 (0.126)
0.038
G 1184 (0.876) 503 (0.855) 1180 (0.904) 615 (0.874)
HWE 0.6113 0.1780 0.6284 0.0256
NT, normotensives; HT, hypertensives; HWE, Hardy-Weinberg equilibrium. 
*Fisher’s exact test was employed for this p value. 
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pants with the AA/AG genotype and 100.39±1.14 mm Hg 
for those with the GG genotype (p=0.017) in postmeno-
pausal EH patients. Thus, the AA/AG genotype was associ-
ated with significantly higher SBP and DBP than the GG 
genotype in postmenopausal EH women (Fig. 1).
Analysis of promoter activities of the A and G alleles of 
rs6682082
To understand the mechanism underlying the association 
between rs6682082 and EH, we investigated the functional 
role of this SNP at the molecular level. As rs6682082 is lo-
cated in the promoter region of the REN gene, we investi-
gated the effect of this SNP on REN transcription. We com-
pared the activities of the promoters containing the A or G 
nucleotide in rs6682082 using a luciferase reporter assay, 
as described in the Methods section. The luciferase activity 
of the A-type promoter was 2.4±0.01 fold higher than that of 
the G-type promoter (Fig. 2). Furthermore, the activity of 
the G (A) promoter, which is the G-type promoter with an A 
at the rs6682082 position, was similarly higher (2.0±0.4 
fold) than that of the G-type promoter. These results sug-
gest that the transcription of the REN gene is differentially 
regulated depending on the nucleotide variant of rs6682082 
and that this SNP itself directly affects the transcriptional 
OR became 1.493 (95% CI=1.069‒2.086) after adjustments 
were made for confounding factors, including BMI, TG, 
HDL, creatinine, and Glu (Table 3). Therefore, the geno-
type of the rs6682082 polymorphism was associated with 
the risk of EH in the female participants (p=0.018), and the 
A allele was an independent positive risk factor for EH in 
female Koreans.
We also analyzed the relationship between blood pres-
sure and the rs6682082 genotype. We included both NT 
and EH individuals in this analysis and used blood pressure 
levels measured before any antihypertensive drug treatment 
for the EH patients. Since the genetics of female patients 
with EH significantly differ before and after menopause, 
further analysis was carried out with the participants whose 
menopause statuses were known. These included 332 and 
448 participants in pre- and post-menopause, respectively. 
A significant relationship between the rs6682082 genotype 
and blood pressure was found in post-menopausal women 
and this relationship was prominent in EH patients. In post-
menopausal EH patients, the mean systolic blood pressure 
(SBP) was 168.05±2.95 mm Hg for participants with the 
AA/AG genotype and 160.57±1.50 mm Hg for those with 
the GG genotype (p=0.003). Likewise, the mean diastolic 
blood pressure (DBP) was 105.32±2.37 mm Hg for partici-
Table 3. rs6682082 Association Analyses with Risk of EH 
Genotype
Male Female
OR 95% CI p value OR 95% CI p value
A-dominance 1.096 0.764‒1.571 0.617 1.493 1.069‒2.086 0.018
A-recessive 2.007 0.714‒5.643 0.186 0.416 0.047‒3.690 0.430
Co-dominance 1.009 0.693‒1.471 0.423 1.539 1.098‒2.159 0.032
EH, essential hypertension; OR, odds ratio; CI, confidence interval; BMI, body mass index; TG, triglyceride; HDL, high-density lipoprotein.
A-dominance, AA+AG vs. GG; A-recessive, AA vs. AG+GG; Co-dominance, AA vs. AG vs. GG; Adjusted for BMI, creatinine, TG, HDL, and glucose. 
Fig. 1. Differences in systolic blood pressure (SBP) and diastolic blood pressure (DBP) by rs6682082 genotype in postmenopausal EH patients. (A) Means of 
SBP were 168.05±2.95 mm Hg in participants with the AA/AG genotype and 160.57±1.50 mm Hg in participants with the GG genotype (p=0.003). (B) Means of 
DBP were 105.32±2.37 mm Hg in participants with the AA/AG genotype and 100.39±1.14 mm Hg in participants with the GG genotype (p=0.017). BP was de-
scribed by mean±standard error. EH, essential hypertension.
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Map-HCB), as there was no genotype data available for 
rs5707 in Koreans. SNPs rs6682082 and rs5707 were not 
noted in LD in both Japanese and Chinese (r2=zero) popula-
tions, suggesting that they may not be found in LD in Kore-
ans either. Thus, rs6682082 is an independent genetic marker 
for EH and BP in Korean women, and associations of rs5707 
with hypertension and blood pressure can be assessed in Ko-
rean populations (Supplementary  Fig. 2, only online). 
Among recent studies of RAS genes for association with 
hypertension,3,4,16,30 rs6682082 has been under consideration 
in a single study, in which no association was found there-
with and uncontrolled arterial hypertension in an ethnic 
Spanish group.30 In 2011, Song, et al.3 identified RAS-related 
genes that were associated with BP in the Korea Association 
Resource subject pool. They analyzed correlations between 
BP and 12 REN SNPs (rs6679960, rs4951307, rs3737656, 
rs1997034, rs11571093, rs2887284, rs2368564, 
rs11571082, rs11571103, rs10900555, rs6693954, and 
rs16853059), which showed no association. The reason 
why none of these SNPs showed any association with BP 
in Korean women is not clear. One reason may be that the 
authors might not have analyzed for gender-specific associ-
ations. Another possibility is that none of these markers is 
linked to rs6682082. The closest marker to rs6682082 is 
rs6693954, which is located 4.3 kb away from rs6682082. 
Although we do not know the LD status of these markers in 
Koreans, they are not found in LD in Japanese and Chinese 
populations, suggesting that these are not in LD in Koreans 
(Haploview Supplementary Fig. 2, only online).
In the present study, we identified a new independent ge-
netic marker, rs6682082, as being strongly associated with 
risk of EH and high BP in Korean women. Blood pressure 
tends to increase with age, more so for women than men. 
Especially after menopause, risk of EH for women increas-
es greatly, thus leading to more female than male EH pa-
activity of the REN gene (Fig. 2).
DISCUSSION
Renin plays a pivotal role in the regulation of blood pres-
sure27 and elevated renin levels are a risk factor for EH. Al-
though renin acts as the rate-limiting step of the RAS cas-
cade, renin has attracted less research attention than other 
candidate proteins in terms of its genetic association with 
EH. Recent development of a renin inhibitor as an antihy-
pertensive drug has rekindled interest in the association be-
tween renin polymorphisms and EH. 
There were several genetic markers of REN that have 
shown positive associations with EH and a few in the pro-
moter region in different ethnic groups.14,18,28 The rs6696954 
and rs5705 showed association with EH in Caucasians and 
the intronic BglI site with EH in a United Arab Emirates 
population.13,18 The rs41317140 (Taq1, C-4036T) in the 5’ 
flanking region of REN showed discrepancies in associa-
tion with EH in different ethnic groups29: it was positively 
associated with EH in a Han population, while no associa-
tion was found in Bangladeshi patients with EH.11
Some renin markers showed significant association with 
elevated blood pressure. rs12750834 (C-5312T) was asso-
ciated with elevated blood pressure in Caucasians.24 
The present study found an association of rs6682082 with 
hypertension and blood pressure in post-menopausal women. 
Interestingly, rs5707 was shown to be associated with high 
blood pressure in post-menopausal Spanish women.12 The 
rs6682082 and rs5707 polymorphisms are located in the pro-
moter and intron 6 of REN, respectively. In order to deter-
mine whether these two markers are linked to each other, we 
analyzed LD status between the two SNPs using Haploview 
4.2 in HapMap Asian populations (HapMap-JPT and Hap-
Fig. 2. Luciferase activity of AS 4.1 cells transfected with renin SNP rs6682082/luciferase gene constructs. The G (A) promoter construct 
was prepared by site-directed mutagenesis of the G allele promoter construct. The relative luciferase activity is presented by mean± 
standard error. *A allele vs. G allele, †G (A) allele vs. G allele. SNP, single-nucleotide polymorphism.
Renin promoter/luciferase constructs  Relative luciferase activity
G allele promoter
A allele promoter
G (A) allele promoter
*p=0.033
†p=0.014
0 1 20.5 1.5 2.5 3
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a new TF that regulates REN expression and affects BP lev-
el, especially in females.
Our study has a few limitations. First, the statistical power 
of this study was limited due to the restricted sample size. 
Second, promoter activity was not supported with endoge-
nous plasma renin levels. Although these limits somewhat 
weaken the power of this study, it is clear that rs66820982 is 
an important independent marker for EH in Korean women. 
In conclusion, we identified the A allele of the rs6682082 
SNP in human REN as a risk factor for EH in Korean wom-
en and suggested a possible mechanism for how this risk 
factor may contribute to the development of EH. Via our 
study, we identified a new regulatory region in REN pro-
moter that influences transcription of the REN gene. Al-
though an SNP (rs5707) has previously been reported to be 
associated with EH and high BP in post-menopausal wom-
en, rs6682082 is the first SNP to show both functional rele-
vance and associations with EH and high BP. Furthermore, 
this is the first report to show a positive genetic risk factor 
for EH in the renin gene of Koreans. 
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Supplementary Fig. 1. Diagram of the renin gene and linkage disequilibrium structure of single nucleotide polymorphisms (rs6682082, 
rs11240688, rs10900555, rs2272237, rs1464816, and rs2368564).
Supplementary Fig. 2. Linkage disequilibrium of renin SNP in East Asian populations, (A) HapMap-JPT and (B) HapMap-HCB (1:rs11571093, 
2:rs11571123, 3:rs11571091, 4:rs2887284, 5:rs2368564, 6:rs5706, 7:rs3795575, 8:rs11571120, 9:rs11571119, 10:rs3730101, 11:rs1157, 12:rs11571117, 
13:rs11571116, 14:rs11571114, 15:rs5707, 16:rs11571083, 17:rs11571083, 18:rs11571082, 19:rs5705, 20:rs11571108, 21:rs11571080, 22:rs11571107, 
23:rs11571104, 24:rs11471103, 25:rs10900555, 26:rs6693954, 27:rs11571102, 28:rs11571079, 29:rs6676670, 30:rs11571078, 31:rs11571101, 
32:rs11571100, 33:rs11240688, 34:rs11571098, 35:rs6668858, 36:rs11571097, 37:rs6681776, 38:rs6682082). SNP, single-nucleotide polymorphism.
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